A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)
about
A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Phase 2, 2-Stage, 2-Cohort S ...... h BRCA Mutation (ABRAZO Study)
@en
type
label
A Phase 2, 2-Stage, 2-Cohort S ...... h BRCA Mutation (ABRAZO Study)
@en
prefLabel
A Phase 2, 2-Stage, 2-Cohort S ...... h BRCA Mutation (ABRAZO Study)
@en
P17
P1476
A PHASE 2, 2-STAGE, 2-COHORT S ...... ND/OR METASTATIC BREAST CANCER
@en
P1813
ABRAZO
@en
P3098
NCT02034916
P4844
P580
2013-12-13T00:00:00Z
P582
2016-09-01T00:00:00Z